FCC
Unknown
9,782 enrolled
EMIRA
Unknown
148 enrolled
The Link Between Clinical and Physiological Sleep Data and Health-related Outcomes
Unknown
5,000 enrolled
CAT_PB
Phase 1 Unknown
500 enrolled
PC-TOX
Unknown
75 enrolled
OPTIMUS
Unknown
80 enrolled
Physical Capacity in Hodgkin Lymphoma Survivors
Phase NA Unknown
40 enrolled
MMetdMH
Unknown
60 enrolled
ButterfLife
Phase NA Unknown
50 enrolled
Pharmacokinetics of Oral Antiplatelet Agents After Distal Gastrectomy
Unknown
20 enrolled
BRANCH-P
Unknown
2,000 enrolled
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
Phase 1 Unknown
100 enrolled
Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life)
Phase NA Unknown
100 enrolled
SCHS
Unknown
63,257 enrolled
Team-based Versus Primary Care Clinician-led Advance Care Planning in Practice-based Research Networks
Phase NA Unknown
1,120 enrolled
HARMOny
Unknown
750 enrolled
Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients
Unknown
300 enrolled
SMAC-1
Unknown
2,000 enrolled
MELS
Unknown
9,500 enrolled
Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer
Phase 2 Unknown
60 enrolled
Cardiovascular Events in GnRH Agonist vs. Antagonist
Phase 2 Unknown
80 enrolled
Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai, China
Phase NA Unknown
10,000 enrolled
Hyperpolarised 13C-Pyruvate MRI Study
Phase NA Unknown
25 enrolled
Development of Photoacoustic Tomography
Unknown
27 enrolled
NSHDS
Unknown
120,000 enrolled
Meta-Analyses of Low-risk Lifestyle Behaviours and Patient Important Outcomes
Unknown
1 enrolled
The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study
Unknown
1,050 enrolled
HARBOR
Unknown
628 enrolled
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Phase 4 Unknown
1,200 enrolled
A Menopause Interactive Decision Aid System
Phase NA Unknown
296 enrolled
HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
Phase 4 Unknown
5,000 enrolled